Gujarat Kidney And Super Speciality (NSE:GKSL) EBIT: ₹231.6 Mil (TTM As of Mar. 2026)

Gujarat Kidney And Super Speciality  (NSE:GKSL) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Gujarat Kidney And Super Speciality's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

where

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Gujarat Kidney And Super Speciality's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

where Working Capital is:

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Gujarat Kidney And Super Speciality's Earnings Yield (Joel Greenblatt) % for today is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gujarat Kidney And Super Speciality EBIT Related Terms

The historical data trend for Gujarat Kidney And Super Speciality's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gujarat Kidney And Super Speciality EBIT Chart

NSE:GKSL vs HCA, THC, DVA: EBIT Comparison

For the Medical Care Facilities subindustry, Gujarat Kidney And Super Speciality's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Gujarat Kidney And Super Speciality EV-to-EBIT vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Gujarat Kidney And Super Speciality's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Gujarat Kidney And Super Speciality's EV-to-EBIT falls into.

Gujarat Kidney And Super Speciality EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹231.6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gujarat Kidney And Super Speciality Business Description